Stock Analysis

When Will Dingdang Health Technology Group Ltd. (HKG:9886) Breakeven?

Published
SEHK:9886

We feel now is a pretty good time to analyse Dingdang Health Technology Group Ltd.'s (HKG:9886) business as it appears the company may be on the cusp of a considerable accomplishment. Dingdang Health Technology Group Ltd. operates as a service provider in the digital health on-demand business in the People’s Republic of China. On 31 December 2023, the HK$1.4b market-cap company posted a loss of CN¥226m for its most recent financial year. Many investors are wondering about the rate at which Dingdang Health Technology Group will turn a profit, with the big question being “when will the company breakeven?” We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.

See our latest analysis for Dingdang Health Technology Group

Dingdang Health Technology Group is bordering on breakeven, according to the 2 Hong Kong Consumer Retailing analysts. They anticipate the company to incur a final loss in 2025, before generating positive profits of CN¥31m in 2026. Therefore, the company is expected to breakeven roughly 2 years from today. How fast will the company have to grow each year in order to reach the breakeven point by 2026? Working backwards from analyst estimates, it turns out that they expect the company to grow 84% year-on-year, on average, which is extremely buoyant. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.

SEHK:9886 Earnings Per Share Growth July 19th 2024

Underlying developments driving Dingdang Health Technology Group's growth isn’t the focus of this broad overview, though, keep in mind that by and large a high growth rate is not out of the ordinary, particularly when a company is in a period of investment.

Before we wrap up, there’s one aspect worth mentioning. Dingdang Health Technology Group currently has no debt on its balance sheet, which is rare for a loss-making growth company, which typically has high debt relative to its equity. The company currently operates purely off its shareholder funding and has no debt obligation, reducing concerns around repayments and making it a less risky investment.

Next Steps:

There are too many aspects of Dingdang Health Technology Group to cover in one brief article, but the key fundamentals for the company can all be found in one place – Dingdang Health Technology Group's company page on Simply Wall St. We've also put together a list of pertinent aspects you should further research:

  1. Valuation: What is Dingdang Health Technology Group worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Dingdang Health Technology Group is currently mispriced by the market.
  2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Dingdang Health Technology Group’s board and the CEO’s background.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.